 Mark Ware, Canopy's chief medical officer, said in an interview that Feilding's "ability to take a scientific look at what would otherwise be considered as controversial therapeutics makes her a very good partner".Feilding's son, Cosmo Feilding Mellen, is the managing director of the partnership.In 1966 Feilding met and formed a relationship with Dutch scientist Bart Huges.